Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Improving the economics of NASH/NAFLD treatment through the use of systems biology
KTH, Centra, Science for Life Laboratory, SciLifeLab.
KTH, Skolan för bioteknologi (BIO), Proteomik och nanobioteknologi. KTH, Centra, Science for Life Laboratory, SciLifeLab.ORCID-id: 0000-0002-6428-5936
Vise andre og tillknytning
2017 (engelsk)Inngår i: Drug Discovery Today, ISSN 1359-6446, E-ISSN 1878-5832, Vol. 22, nr 10, s. 1532-1538Artikkel, forskningsoversikt (Fagfellevurdert) Published
Abstract [en]

Nonalcoholic steatohepatitis (NASH) is a severe form of nonalcoholic fatty liver disease (NAFLD). We surveyed NASH therapies currently in development, and found a significant variety of targets and approaches. Evaluation and clinical testing of these targets is an expensive and time-consuming process. Systems biology approaches could enable the quantitative evaluation of the likely efficacy and safety of different targets. This motivated our review of recent systems biology studies that focus on the identification of targets and development of effective treatments for NASH. We discuss the potential broader use of genome-scale metabolic models and integrated networks in the validation of drug targets, which could facilitate more productive and efficient drug development decisions for the treatment of NASH.

sted, utgiver, år, opplag, sider
ELSEVIER SCI LTD , 2017. Vol. 22, nr 10, s. 1532-1538
HSV kategori
Identifikatorer
URN: urn:nbn:se:kth:diva-217446DOI: 10.1016/j.drudis.2017.07.005ISI: 000413799500008PubMedID: 28736156Scopus ID: 2-s2.0-85026322326OAI: oai:DiVA.org:kth-217446DiVA, id: diva2:1158036
Merknad

QC 20171117

Tilgjengelig fra: 2017-11-17 Laget: 2017-11-17 Sist oppdatert: 2020-01-10bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekstPubMedScopus

Personposter BETA

Lee, SunjaeNielsen, JensUhlén, MathiasMardinoglu, Adil

Søk i DiVA

Av forfatter/redaktør
Borén, ChristoferLee, SunjaeNielsen, JensUhlén, MathiasMardinoglu, Adil
Av organisasjonen
I samme tidsskrift
Drug Discovery Today

Søk utenfor DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 136 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf